Presentation "Top Reasons to Invest in France"at the GIH - Bio International Convention 2025 - Context: France is a major player in terms of biotech innovation, and the French authorities have set an ambitious approach through the France 2030 Strategy. The GIH at Bio International Convention 2025 is the ideal occasion to introduce this Strategy to an international audience and to highlight partenring opportunities with French biotech ecosystem (including research, clinical trials, AI, etc.). - Goal: Present the main assets and opportunities of France to an international audience in order to foster partnering opportunities. - Target audience: VCs, biotech and pharma companies, policymakers, incubators, bioclusters. Preliminary Program: 1. Introduction by the HAI (Health Innovation Agency), administered by the Secretary General for Investment (SGPI), under the authority of the Prime Minister. 2. Pfizer 3. France BioLead